Nanobodies: natural single-domain antibodies.
暂无分享,去创建一个
[1] L. Wyns,et al. Identification of a universal VHH framework to graft non-canonical antigen-binding loops of camel single-domain antibodies. , 2005, Journal of molecular biology.
[2] C. J. Bond,et al. Comprehensive Analysis of the Factors Contributing to the Stability and Solubility of Autonomous Human VH Domains* , 2008, Journal of Biological Chemistry.
[3] L. Wyns,et al. Antigen Specificity and High Affinity Binding Provided by One Single Loop of a Camel Single-domain Antibody* , 2001, The Journal of Biological Chemistry.
[4] E. Wanker,et al. A Fluorescent Two-hybrid Assay for Direct Visualization of Protein Interactions in Living Cells*S , 2008, Molecular & Cellular Proteomics.
[5] L. Wyns,et al. Selection and identification of single domain antibody fragments from camel heavy‐chain antibodies , 1997, FEBS letters.
[6] J. Steyaert,et al. Substrate-dependent modulation of enzyme activity by allosteric effector antibodies. , 2009, Biochimica et biophysica acta.
[7] C. Chothia,et al. Domain association in immunoglobulin molecules. The packing of variable domains. , 1985, Journal of molecular biology.
[8] Shenghua Li,et al. Selection of hapten-specific single-domain antibodies from a non-immunized llama ribosome display library. , 2003, Journal of immunological methods.
[9] T. Surrey,et al. Selection of Genetically Encoded Fluorescent Single Domain Antibodies Engineered for Efficient Expression in Escherichia coli* , 2007, Journal of Biological Chemistry.
[10] Jakub Toczek,et al. Nanobodies Targeting Mouse/Human VCAM1 for the Nuclear Imaging of Atherosclerotic Lesions , 2012, Circulation research.
[11] L. Wyns,et al. A single-domain antibody fragment in complex with RNase A: non-canonical loop structures and nanomolar affinity using two CDR loops. , 1999, Structure.
[12] G. Winter,et al. Aggregation-resistant domain antibodies selected on phage by heat denaturation , 2004, Nature Biotechnology.
[13] L. Wyns,et al. Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[14] David E. Gloriam,et al. ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome , 2007, Nature Methods.
[15] L. James,et al. Crystal structure of HEL4, a soluble, refoldable human V(H) single domain with a germ-line scaffold. , 2004, Journal of molecular biology.
[16] F. Grosveld,et al. Generation of heavy-chain-only antibodies in mice , 2006, Proceedings of the National Academy of Sciences.
[17] Jeffrey J. Gray,et al. Analysis and Modeling of the Variable Region of Camelid Single-Domain Antibodies , 2011, The Journal of Immunology.
[18] L. Wyns,et al. Strong in Vivo Maturation Compensates for Structurally Restricted H3 Loops in Antibody Repertoires* , 2005, Journal of Biological Chemistry.
[19] L. Wyns,et al. Single‐domain antibody fragments with high conformational stability , 2002, Protein science : a publication of the Protein Society.
[20] L. Wyns,et al. Antigen binding and solubility effects upon the veneering of a camel VHH in framework-2 to mimic a VH. , 2005, Journal of molecular biology.
[21] I. Mårtensson,et al. The pre‐B cell receptor checkpoint , 2010, FEBS letters.
[22] Sachdev S Sidhu,et al. Contributions of CDR3 to V H H domain stability and the design of monobody scaffolds for naive antibody libraries. , 2003, Journal of molecular biology.
[23] D. Schüler,et al. Magnetosome Expression of Functional Camelid Antibody Fragments (Nanobodies) in Magnetospirillum gryphiswaldense , 2011, Applied and Environmental Microbiology.
[24] S. Phillips,et al. Single Domain Intracellular Antibodies from Diverse Libraries , 2010, The Journal of Biological Chemistry.
[25] Nick Devoogdt,et al. Preclinical screening of anti‐HER2 nanobodies for molecular imaging of breast cancer , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[26] S. Morrison. Murine heavy chain disease , 1978, European journal of immunology.
[27] L. Hammarström,et al. Genetic polymorphism of the IGHG3 gene in cattle , 1997, Immunogenetics.
[28] I. Kacskovics,et al. Porcine IgG: structure, genetics, and evolution , 2009, Immunogenetics.
[29] J. Appleton,et al. Application of Monoclonal Antibodies in Functional and Comparative Investigations of Heavy-Chain Immunoglobulins in New World Camelids , 2005, Clinical Diagnostic Laboratory Immunology.
[30] S. Muyldermans,et al. A bispecific nanobody to provide full protection against lethal scorpion envenoming , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[31] L. Hammarström,et al. Therapeutic effect of llama derived VHH fragments against Streptococcus mutans on the development of dental caries , 2006, Applied Microbiology and Biotechnology.
[32] G. Winter,et al. Repertoires of aggregation-resistant human antibody domains. , 2007, Protein engineering, design & selection : PEDS.
[33] J. Hall,et al. Isolation, characterization and pentamerization of alpha-cobrotoxin specific single-domain antibodies from a naïve phage display library: preliminary findings for antivenom development. , 2007, Toxicon : official journal of the International Society on Toxinology.
[34] J. Tanha,et al. Prokaryotic expression of antibodies , 2005, Cancer and Metastasis Reviews.
[35] S. Muyldermans,et al. Antigen-Binding Repertoire Single-Domain Antibody Contributes to the A Novel Promiscuous Class of Camelid , 2010 .
[36] G. Vriend,et al. Isolation of Llama Antibody Fragments for Prevention of Dandruff by Phage Display in Shampoo , 2005, Applied and Environmental Microbiology.
[37] S. Muyldermans,et al. Naturally occurring antibodies devoid of light chains , 1993, Nature.
[38] H. Leonhardt,et al. Novel antibody derivatives for proteome and high-content analysis , 2010, Analytical and bioanalytical chemistry.
[39] S. Muyldermans,et al. Heavy‐chain only antibodies derived from dromedary are secreted and displayed by mouse B cells , 2003, Immunology.
[40] C. Cambillau,et al. Camelid heavy-chain variable domains provide efficient combining sites to haptens. , 2000, Biochemistry.
[41] R. Weiss,et al. Generation of a Family-specific Phage Library of Llama Single Chain Antibody Fragments That Neutralize HIV-1* , 2010, The Journal of Biological Chemistry.
[42] Jennifer A. Smith,et al. Supplementary Material References Subscriptions Permissions Email Alerts Expression of a Dromedary Heavy Chain-Only Antibody and B Cell Development in the Mouse , 2013 .
[43] I. Achour,et al. Tetrameric and Homodimeric Camelid IgGs Originate from the Same IgH Locus , 2008, The Journal of Immunology.
[44] A. Lesk,et al. Standard conformations for the canonical structures of immunoglobulins. , 1997, Journal of molecular biology.
[45] Jamshid Tanha,et al. Pentamerization of single-domain antibodies from phage libraries: a novel strategy for the rapid generation of high-avidity antibody reagents. , 2004, Journal of molecular biology.
[46] G. Sutherland,et al. Kinetic analysis of novel mono‐ and multivalent VHH‐fragments and their application for molecular imaging of brain tumours , 2010, British journal of pharmacology.
[47] James B Delehanty,et al. Facile generation of heat-stable antiviral and antitoxin single domain antibodies from a semisynthetic llama library. , 2006, Analytical chemistry.
[48] S. Muyldermans,et al. Emergence and evolution of functional heavy-chain antibodies in Camelidae. , 2003, Developmental and comparative immunology.
[49] Mark M. Davis,et al. Structural Insight into Pre-B Cell Receptor Function , 2007, Science.
[50] Y. Hagihara,et al. Stabilization of an Immunoglobulin Fold Domain by an Engineered Disulfide Bond at the Buried Hydrophobic Region* , 2007, Journal of Biological Chemistry.
[51] H. Leonhardt,et al. Engineering antibodies and proteins for molecular in vivo imaging. , 2011, Current opinion in biotechnology.
[52] S. Muyldermans,et al. Dual Beneficial Effect of Interloop Disulfide Bond for Single Domain Antibody Fragments* , 2011, The Journal of Biological Chemistry.
[53] I. Wilson,et al. Crystal Structure of a Shark Single-Domain Antibody V Region in Complex with Lysozyme , 2004, Science.
[54] T. Rabbitts,et al. Intracellular antibodies and cancer: New technologies offer therapeutic opportunities , 2010, BioEssays : news and reviews in molecular, cellular and developmental biology.
[55] S. Muyldermans,et al. Nanobodies, a promising tool for species-specific diagnosis of Taenia solium cysticercosis. , 2009, International journal for parasitology.
[56] B. Engel,et al. Passive immunization with llama single-domain antibody fragments reduces foot-and-mouth disease transmission between pigs. , 2009, Vaccine.
[57] Serge Muyldermans,et al. Single Domain Antibodies Derived from Dromedary Lymph Node and Peripheral Blood Lymphocytes Sensing Conformational Variants of Prostate-specific Antigen* , 2004, Journal of Biological Chemistry.
[58] Shenghua Li,et al. Affinity maturation of a V(H)H by mutational hotspot randomization. , 2005, Journal of immunological methods.
[59] M. Taussig,et al. Crystal structure of a Staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: structural basis for recognition of B-cell receptors and superantigen activity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[60] Corella S. Casas-Delucchi,et al. Modulation of protein properties in living cells using nanobodies , 2010, Nature Structural &Molecular Biology.
[61] Jan Reyelt,et al. Single domain antibodies from llama effectively and specifically block T cell ecto‐ADP‐ribosyltransferase ART2.2 in vivo , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[62] M. Cristina Cardoso,et al. A Versatile Nanotrap for Biochemical and Functional Studies with Fluorescent Fusion Proteins*S , 2008, Molecular & Cellular Proteomics.
[63] D. Christ,et al. Sequence determinants of protein aggregation in human VH domains. , 2008, Protein engineering, design & selection : PEDS.
[64] S. Muyldermans,et al. The specific variable domain of camel heavy-chain antibodies is encoded in the germline. , 1998, Journal of molecular biology.
[65] L. Wyns,et al. Efficient Targeting of Conserved Cryptic Epitopes of Infectious Agents by Single Domain Antibodies , 2004, Journal of Biological Chemistry.
[66] S. Rasmussen,et al. Structure of a nanobody-stabilized active state of the β2 adrenoceptor , 2010, Nature.
[67] H. Hoogenboom,et al. Selecting and screening recombinant antibody libraries , 2005, Nature Biotechnology.
[68] R. Kontermann,et al. Strategies for extended serum half-life of protein therapeutics. , 2011, Current opinion in biotechnology.
[69] P. Hudson,et al. Engineered antibody fragments and the rise of single domains , 2005, Nature Biotechnology.
[70] L. Wyns,et al. Camel single‐domain antibody inhibits enzyme by mimicking carbohydrate substrate , 1998, Proteins.
[71] L. Wyns,et al. Camel heavy‐chain antibodies: diverse germline VHH and specific mechanisms enlarge the antigen‐binding repertoire , 2000, The EMBO journal.
[72] S. Muyldermans,et al. A bacterial-two-hybrid selection system for one-step isolation of intracellularly functional Nanobodies. , 2012, Archives of biochemistry and biophysics.
[73] M. Kutzler,et al. Effector Functions of Camelid Heavy-Chain Antibodies in Immunity to West Nile Virus , 2009, Clinical and Vaccine Immunology.
[74] V. Labas,et al. A one‐step exclusion‐binding procedure for the purification of functional heavy‐chain and mammalian‐type γ‐globulins from camelid sera , 2009, Biotechnology and applied biochemistry.
[75] J. Appleton,et al. Contributions of Conventional and Heavy-Chain IgG to Immunity in Fetal, Neonatal, and Adult Alpacas , 2010, Clinical and Vaccine Immunology.
[76] M. Jaramillo,et al. Differential tumor-targeting abilities of three single-domain antibody formats. , 2010, Cancer letters.
[77] G. V. van Dongen,et al. Facile labelling of an anti-epidermal growth factor receptor Nanobody with 68Ga via a novel bifunctional desferal chelate for immuno-PET , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[78] L. Wyns,et al. Camel Single-domain Antibodies as Modular Building Units in Bispecific and Bivalent Antibody Constructs* , 2001, The Journal of Biological Chemistry.
[79] S. Muyldermans,et al. Single-domain antibodies as building blocks for novel therapeutics. , 2008, Current opinion in pharmacology.
[80] Charles Duyckaerts,et al. Llama VHH antibody fragments against GFAP: better diffusion in fixed tissues than classical monoclonal antibodies , 2009, Acta Neuropathologica.
[81] L. Frenken,et al. The structure of the llama heavy chain constant genes reveals a mechanism for heavy-chain antibody formation , 1999, Immunogenetics.
[82] C. Verrips,et al. Recent advances in the large-scale production of antibody fragments using lower eukaryotic microorganisms. , 1998, Research in immunology.
[83] C. Dobson,et al. Structure and properties of a complex of α-synuclein and a single-domain camelid antibody. , 2010, Journal of molecular biology.
[84] H. de Haard,et al. Properties, production, and applications of camelid single-domain antibody fragments , 2007, Applied Microbiology and Biotechnology.
[85] S. Muyldermans,et al. VHH, bivalent domains and chimeric Heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI'. , 2008, Molecular immunology.
[86] J. Tanha,et al. Neutralization of Clostridium difficile Toxin A with Single-domain Antibodies Targeting the Cell Receptor Binding Domain* , 2011, The Journal of Biological Chemistry.
[87] L. Wyns,et al. Canonical antigen-binding loop structures in immunoglobulins: more structures, more canonical classes? , 2000, Journal of molecular biology.
[88] Jiye Shi,et al. Camelid Single-Domain Antibodies Analysis and Modeling of the Variable Region of , 2011 .
[89] S. Muyldermans,et al. Development of Cys38 knock-out and humanized version of NbAahII10 nanobody with improved neutralization of AahII scorpion toxin. , 2011, Protein engineering, design & selection : PEDS.
[90] S. Muyldermans,et al. General Strategy to Humanize a Camelid Single-domain Antibody and Identification of a Universal Humanized Nanobody Scaffold* , 2009, Journal of Biological Chemistry.
[91] T. Honjo,et al. Organization of the human immunoglobulin heavy-chain locus. , 1996, Advances in immunology.
[92] Jan Steyaert,et al. Crystal structure of the N-terminal domain of the secretin GspD from ETEC determined with the assistance of a nanobody. , 2009, Structure.
[93] K. Conrath,et al. Neutralisation of venom-induced haemorrhage by IgG from camels and llamas immunised with viper venom and also by endogenous, non-IgG components in camelid sera. , 2006, Toxicon : official journal of the International Society on Toxinology.
[94] S. Muyldermans,et al. Disulfide bond introduction for general stabilization of immunoglobulin heavy-chain variable domains. , 2008, Journal of molecular biology.
[95] M. Cogné,et al. Immunoglobulin gene alterations in human heavy chain diseases. , 1989, Research in immunology.
[96] P. Chames,et al. Bispecific antibodies for cancer therapy , 2009, Current opinion in drug discovery & development.
[97] Shohei Koide,et al. Exploring the capacity of minimalist protein interfaces: interface energetics and affinity maturation to picomolar KD of a single-domain antibody with a flat paratope. , 2007, Journal of molecular biology.
[98] W. Weissenhorn,et al. Crystal Structure of the Neutralizing Llama VHH D7 and Its Mode of HIV-1 gp120 Interaction , 2010, PloS one.
[99] A. de Marco. Biotechnological applications of recombinant single-domain antibody fragments , 2011, Microbial cell factories.
[100] J. Tanha,et al. Engineered Single-Domain Antibodies with High Protease Resistance and Thermal Stability , 2011, PloS one.
[101] Hamid Rajabi Memari,et al. Production and characterization of anti‐(mucin MUC1) single‐domain antibody in tobacco (Nicotiana tabacum cultivar Xanthi) , 2007, Biotechnology and applied biochemistry.
[102] L. Wyns,et al. LOSS OF SPLICE CONSENSUS SIGNAL IS RESPONSIBLE FOR THE REMOVAL OF THE ENTIRE CH1 DOMAIN OF THE FUNCTIONAL CAMEL IGG2A HEAVY-CHAIN ANTIBODIES' , 1999 .
[103] L. Hammarström,et al. Lactobacilli producing bispecific llama-derived anti-rotavirus proteins in vivo for rotavirus-induced diarrhea. , 2011, Future microbiology.
[104] C. Cambillau,et al. Lateral recognition of a dye hapten by a llama VHH domain. , 2001, Journal of molecular biology.
[105] R. Mariuzza,et al. Molecular recognition in antibody-antigen complexes. , 2002, Advances in protein chemistry.
[106] M. Affolter,et al. Fluorescent fusion protein knockout mediated by anti-GFP nanobody , 2011, Nature Structural &Molecular Biology.
[107] N. Devoogdt,et al. Immuno-imaging using nanobodies. , 2011, Current opinion in biotechnology.
[108] R. Weiss,et al. Llama Antibody Fragments Recognizing Various Epitopes of the CD4bs Neutralize a Broad Range of HIV-1 Subtypes A, B and C , 2012, PloS one.
[109] Sylvain Moineau,et al. Llama Antibodies against a Lactococcal Protein Located at the Tip of the Phage Tail Prevent Phage Infection , 2005, Journal of bacteriology.
[110] A. Desmyter,et al. Functional heavy-chain antibodies in Camelidae. , 2001, Advances in immunology.
[111] Serge Muyldermans,et al. Kinetic and Affinity Predictions of a Protein-Protein Interaction Using Multivariate Experimental Design* , 2002, The Journal of Biological Chemistry.
[112] Lode Wyns,et al. Potent enzyme inhibitors derived from dromedary heavy‐chain antibodies , 1998, The EMBO journal.
[113] L. Riechmann,et al. ‘Camelising’ human antibody fragments: NMR studies on VH domains , 1994, FEBS letters.
[114] Liesbet Lagae,et al. Specific cell targeting with nanobody conjugated branched gold nanoparticles for photothermal therapy. , 2011, ACS nano.
[115] S. Muyldermans,et al. TAFIa inhibiting nanobodies as profibrinolytic tools and discovery of a new TAFIa conformation , 2011, Journal of thrombosis and haemostasis : JTH.
[116] L. Wyns,et al. Comparison of llama VH sequences from conventional and heavy chain antibodies. , 1997, Molecular immunology.
[117] T. Baral,et al. Isolation of functional single domain antibody by whole cell immunization: implications for cancer treatment. , 2011, Journal of immunological methods.
[118] R. Weiss,et al. Nanobodies with in vitro neutralizing activity protect mice against H5N1 influenza virus infection. , 2011, The Journal of infectious diseases.
[119] J. Stam,et al. Improved anti-IgG and HSA affinity ligands: clinical application of VHH antibody technology. , 2007, Journal of immunological methods.
[120] J. Bourgeois,et al. Cell‐penetrating anti‐GFAP VHH and corresponding fluorescent fusion protein VHH‐GFP spontaneously cross the blood‐brain barrier and specifically recognize astrocytes: application to brain imaging , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[121] S. Koide. Engineering of recombinant crystallization chaperones. , 2009, Current opinion in structural biology.
[122] S. Howorka,et al. SbsB structure and lattice reconstruction unveil Ca2+ triggered S-layer assembly , 2012, Nature.
[123] Lode Wyns,et al. Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme , 1996, Nature Structural Biology.
[124] L. Daley. The significance of heavy-chain antibodies to camelid immunity , 2007 .
[125] U. Wernery,et al. Analysis of camelid IgG for antivenom development: Immunoreactivity and preclinical neutralisation of venom-induced pathology by IgG subclasses, and the effect of heat treatment. , 2010, Toxicon : official journal of the International Society on Toxinology.
[126] Matthias J. Feige,et al. An unfolded CH1 domain controls the assembly and secretion of IgG antibodies. , 2009, Molecular cell.
[127] J. Holz. The TITAN trial--assessing the efficacy and safety of an anti-von Willebrand factor Nanobody in patients with acquired thrombotic thrombocytopenic purpura. , 2012, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[128] J. Frère,et al. β-Lactamase Inhibitors Derived from Single-Domain Antibody Fragments Elicited in the Camelidae , 2001, Antimicrobial Agents and Chemotherapy.
[129] T. Niewold,et al. Selection and optimization of proteolytically stable llama single-domain antibody fragments for oral immunotherapy , 2006, Applied Microbiology and Biotechnology.
[130] S. Muyldermans,et al. Heavy-chain antibodies in Camelidae; a case of evolutionary innovation , 2002, Immunogenetics.
[131] I. Wilson,et al. Maturation of shark single-domain (IgNAR) antibodies: evidence for induced-fit binding. , 2007, Journal of molecular biology.
[132] H. Ewers,et al. A simple, versatile method for GFP-based super-resolution microscopy via nanobodies , 2012, Nature Methods.
[133] S. Muyldermans,et al. Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor. , 2006, Nature medicine.
[134] Jan Steyaert,et al. Nanobody stabilization of G protein-coupled receptor conformational states. , 2011, Current opinion in structural biology.
[135] A M Lesk,et al. Structural repertoire of the human VH segments. , 1992, Journal of molecular biology.
[136] J. Steyaert,et al. Constraining enzyme conformational change by an antibody leads to hyperbolic inhibition. , 2011, Journal of molecular biology.
[137] C. Verrips,et al. Enhancement of Polymeric Immunoglobulin Receptor Transcytosis by Biparatopic VHH , 2011, PloS one.
[138] C. Shoemaker,et al. Alpaca (Lama pacos) as a convenient source of recombinant camelid heavy chain antibodies (VHHs). , 2007, Journal of immunological methods.
[139] S. Muyldermans,et al. Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains. , 1994, Protein engineering.
[140] Heinrich Leonhardt,et al. Targeting and tracing antigens in live cells with fluorescent nanobodies , 2006, Nature Methods.
[141] Serge Muyldermans,et al. Efficient cancer therapy with a nanobody-based conjugate. , 2004, Cancer research.
[142] C. Francavilla,et al. Immunological applications of single-domain llama recombinant antibodies isolated from a naïve library. , 2009, Protein engineering, design & selection : PEDS.
[143] J. W. Bos,et al. Isolation of antigen specific llama VHH antibody fragments and their high level secretion by Saccharomyces cerevisiae. , 2000, Journal of biotechnology.
[144] L. Hood,et al. gamma Heavy chain disease in man: cDNA sequence supports partial gene deletion model. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[145] E. Padlan,et al. Anatomy of the antibody molecule. , 1994, Molecular immunology.
[146] B. de Geus,et al. Llama heavy-chain V regions consist of at least four distinct subfamilies revealing novel sequence features. , 2000, Molecular immunology.
[147] S. Muyldermans,et al. Engineering camel single-domain antibodies and immobilization chemistry for human prostate-specific antigen sensing. , 2005, Analytical chemistry.
[148] E. Remaut,et al. Formatted anti-tumor necrosis factor alpha VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis. , 2006, Arthritis and rheumatism.
[149] M. Seman,et al. Single domain antibodies: promising experimental and therapeutic tools in infection and immunity , 2009, Medical Microbiology and Immunology.
[150] Nick Deschacht,et al. A Case Of Convergence: Why Did a Simple Alternative to Canonical Antibodies Arise in Sharks and Camels? , 2011, PLoS biology.
[151] M. Flajnik,et al. Origin and evolution of the adaptive immune system: genetic events and selective pressures , 2010, Nature Reviews Genetics.
[152] C T Verrips,et al. Comparison of physical chemical properties of llama VHH antibody fragments and mouse monoclonal antibodies. , 1999, Biochimica et biophysica acta.